CS logo
small CS logo
Seconda Università degli Studi di Napoli

Napoli, Italy

About Seconda Università degli Studi di Napoli


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
EMD Serono Research & Development Institute, Inc.
4
Biogen
2
Amgen
1
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Gilead Sciences
1
Global Blood Therapeutics
1
Merck KGaA, Darmstadt, Germany
1
Symphogen A/S
1
Takeda
1
Tigenix S.A.U.
1
Total Rows: 11

Clinical Trials at Seconda Università degli Studi di Napoli


During the past decade, Seconda Università degli Studi di Napoli conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
2010-09-27
2017-01-25
Completed
488
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B
2011-04-01
2015-07-01
Completed
751
Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease
2012-07-01
2016-11-01
Completed
278
Screening Platform for Clinical Trials in Advanced Colorectal Cancer
2013-09-01
2020-03-10
Completed
668
Conventional Hemodialysis Vs Short Daily Hemodialysis for Patients Coming From Peritoneal Dialysis (HAPD/CAPD)
2014-02-01
2017-12-01
Unknown status
144
Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer
2014-03-06
2017-04-26
Completed
254
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
2015-03-24
2019-12-03
Completed
792
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
2015-08-13
2019-08-08
Terminated
1,653

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Seconda Università degli Studi di Napoli" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 4 trials, followed by "Biogen" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Seconda Università degli Studi di Napoli" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEMD Serono Research &Development Institute,Inc.: 4EMD Serono Research &Development Institute,Inc.: 4Biogen: 2Biogen: 2Amgen: 1Amgen: 1Azienda Ospedaliero-UniversitariaConsorziale Policlinicodi Bari: 1Azienda Ospedaliero-UniversitariaConsorziale Policlinicodi Bari: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Gilead Sciences: 1Gilead Sciences: 1Global Blood Therapeutics: 1Global Blood Therapeutics: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1Symphogen A/S: 1Symphogen A/S: 1Takeda: 1Takeda: 1

Created with Highcharts 11.1.0Top CollaboratorsMerck KGaA,Darmstadt, Germany: 4Merck KGaA,Darmstadt, Germany: 4

Clinical Trials Conditions at Seconda Università degli Studi di Napoli


According to Clinical.Site data, the most researched conditions in "Seconda Università degli Studi di Napoli" are "Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification" (1 trials), "Advanced Colorectal Cancer" (1 trials), "Alzheimer's Disease" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Chronic Hepatitis B" (1 trials). Many other conditions were trialed in "Seconda Università degli Studi di Napoli" in a lesser frequency.

Clinical Trials Intervention Types at Seconda Università degli Studi di Napoli


Most popular intervention types in "Seconda Università degli Studi di Napoli" are "Drug" (12 trials), "Other" (3 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (3 trials), "Placebo" (3 trials), "Capecitabine" (2 trials), "5-Fluorouracil" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Seconda Università degli Studi di Napoli


The vast majority of trials in "Seconda Università degli Studi di Napoli" are 15 trials for "All" genders.

Clinical Trials Status at Seconda Università degli Studi di Napoli


Currently, there are NaN active trials in "Seconda Università degli Studi di Napoli". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Seconda Università degli Studi di Napoli, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Seconda Università degli Studi di Napoli, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 4Phase 2: 4Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Active, not recruiting: 3Active, not recruiting: 3Terminated: 3Terminated: 3Unknown status: 1Unknown status: 1